Serum exosomes derived from spontaneously hypertensive rats induce cardiac hypertrophy in vitro and in vivo by increasing autocrine release of angiotensin II in cardiomyocytes
Biochemical Pharmacology · 2023
DOI: 10.1016/j.bcp.2023.115462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2023. Verfasst von Jingwei Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical…. Hauptthemen laut MEDLINE: Exosomes, Hypertension. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project, Guangzhou Municipal Science and Technology Bureau, Guangdong Medical Research Foundation.
Abstract (Originalsprache)
Identifying the key factors mediating the progression from hypertension to cardiac hypertrophy is critically important for developing a strategy to protect against heart failure. Serum exosomes have been revealed to be involved in the development of cardiovascular disease. In the current study, we found that either serum or serum exosomes derived from SHR induced hypertrophy in H9c2 cardiomyocytes. SHR Exo injection through the tail vein for 8 weeks induced left ventricular wall thickening and decreased cardiac function in C57BL/6 mice. SHR Exo carried the renin-angiotensin system (RAS) proteins AGT, renin, and ACE into cardiomyocytes, which increased the autocrine secretion of Ang II. Moreover, the AT1-type receptor antagonist telmisartan prevented hypertrophy of H9c2 cells induced by SHR Exo.These results identified a novel role of exosomes derived from SHR serum in cardiac hypertrophy and revealed that SHR Exo induced cardiac hypertrophy by carrying AGT, renin, and ACE proteins into cardiomyocytes to increase their autocrine secretion of Ang II. The emergence of this new mechanism will help us better understand how hypertension progresses to cardiac hypertrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China; These authors contributed equall…
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- Department of Ultrasound, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, Guangdong 510220, China. Electronic address: guo8186@126.com.
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China. Electronic address: jianwenmao@g…
Förderung
- Guangzhou Municipal Science and Technology Project
- Guangzhou Municipal Science and Technology Bureau
- Guangdong Medical Research Foundation
- Health Commission of Guangdong Province
Zitieren
APA
Yu, J., Tang, Y., Wang, Y., Zhou, M., Li, Y., Hong, J., Li, C., Xu, B., Guo, X., & Mao, J. (2023). Serum exosomes derived from spontaneously hypertensive rats induce cardiac hypertrophy in vitro and in vivo by increasing autocrine release of angiotensin II in cardiomyocytes. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2023.115462
Vancouver
Yu J, Tang Y, Wang Y, Zhou M, Li Y, Hong J, et al. Serum exosomes derived from spontaneously hypertensive rats induce cardiac hypertrophy in vitro and in vivo by increasing autocrine release of angiotensin II in cardiomyocytes. Biochemical Pharmacology. 2023. doi:10.1016/j.bcp.2023.115462
BibTeX
@article{Yu2023,
author = {Yu, Jingwei and Tang, Yuan and Wang, Yu and Zhou, Mi and Li, Yanwen and Hong, Jiahuan and Li, Chunmei and Xu, Bin and Guo, Xinmin and Mao, Jianwen},
title = {Serum exosomes derived from spontaneously hypertensive rats induce cardiac hypertrophy in vitro and in vivo by increasing autocrine release of angiotensin II in cardiomyocytes},
journal = {Biochemical Pharmacology},
year = {2023},
doi = {10.1016/j.bcp.2023.115462}
}
EUVIMED